Book Chapter
Orlistat and Sibutramine in the Management of Obesity
Holly Wyatt
Endocrine Updates, 1, Volume 26, Overweight and the Metabolic Syndrome, Pages 255-279
Book Chapter
Weight Loss Medications and the Metabolic Syndrome
Linda L. Buckley and Daniel Berressen
Contemporary Endocrinology, 2009, Insulin Resistance, III, Pages 301-322
Book Chapter
Weight-Loss Drugs
Current and on the Horizon
George Bray and Frank Greenway
Contemporary Endocrinology, 2007, Treatment of the Obese Patient, Part II, Pages 341-368
Book Chapter
The Obesity Bias
2006, Obesity Management in Family Practice, Pages 15-22
Book Chapter
Pharmacotherapy of Obesity
George A. Bray
Nutrition and Health, 2005, The Management of Eating Disorders and Obesity, III, Pages 241-275
Book Chapter
Obesity and Its Treatment in Type 2 Diabetes
Frank L. Greenway and William T. Cefalu
Contemporary Endocrinology, 2008, Type 2 Diabetes Mellitus, Pages 333-350
Book Chapter
Overview of the Treatment of Obesity
Neil S. Freedman
Current Clinical Practice, 2007, Primary Care Sleep Medicine, Pages 161-170
Journal Article
Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity
Donna H. Ryan
Endocrine, 2000, Volume 13, Number 2, Pages 193-199
Journal Article
Effectiveness of weight loss and maintenance interventions in women
Marion J. Franz
Current Diabetes Reports, 2004, Volume 4, Number 5, Pages 387-393
Journal Article
What are the risks and the benefits of current and emerging weight-loss medications?
Jamie R. Robinson and Kevin D. Niswender
Current Diabetes Reports, 2009, Volume 9, Number 5, Pages 368-375